Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€205.20
12.05.24
€207.00
12.05.25
1.36%
12:39

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
buy
Twist Bioscience Corp

Start price
Target price
Perf. (%)
€37.40
03.05.24
€41.76
03.05.25
17.57%
13.05.24

buy
Twist Bioscience Corp

Start price
Target price
Perf. (%)
€34.80
03.05.24
€37.06
03.05.25
26.35%
13.05.24

buy
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€2.04
11.04.24
€4.65
11.04.25
144.02%
13.05.24

buy
Twist Bioscience Corp

Start price
Target price
Perf. (%)
€29.63
10.04.24
€37.22
10.04.25
48.40%
13.05.24

Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.80
28.03.24
€5.56
28.03.25
-43.50%
13.05.24

buy
Avid Bioservices Inc

Start price
Target price
Perf. (%)
€6.00
09.03.24
€7.50
09.03.25
27.50%
13.05.24

Could be worthwhile Investment >10% per year
buy
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€2.53
07.03.24
€4.58
07.03.25
97.07%
13.05.24

buy
Elanco Animal Health Inc.

Start price
Target price
Perf. (%)
€15.18
27.02.24
€15.66
27.02.25
4.28%
12:26

Alkermes plc

Start price
Target price
Perf. (%)
€28.00
20.02.24
€23.09
20.02.25
-20.00%
13.05.24

buy
Ipsen S.A.

Start price
Target price
Perf. (%)
€105.00
13.02.24
€109.00
13.02.25
15.43%
12:47

Could be worthwhile Investment >10% per year
buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€2.33
13.02.24
€3.74
13.02.25
84.03%
13.05.24

buy
Deciphera Pharmaceuticals

Start price
Target price
Perf. (%)
€13.12
08.02.24
€21.40
08.02.25
78.42%
13.05.24

buy
Bayer AG ADR

Start price
Target price
Perf. (%)
€7.25
06.02.24
€7.00
06.02.25
0.38%
13.05.24

EBIT growth >5% per year expected
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.84
04.02.24
€7.00
31.10.25
64.98%
13.05.24

Could be very worthwhile Investment >20% year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.00
04.02.24
€7.00
31.03.26
27.50%
13.05.24

Could be very worthwhile Investment >20% year
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€603.00
01.02.24
€579.60
01.02.25
16.45%
13:51

buy
Teva Pharmaceutical Industries Ltd ADR

Start price
Target price
Perf. (%)
€11.00
29.01.24
€13.86
29.01.25
43.64%
13:44

buy
Twist Bioscience Corp

Start price
Target price
Perf. (%)
€30.06
25.01.24
€41.54
25.01.25
46.27%
13.05.24

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€584.00
24.01.24
€641.90
24.01.25
20.24%
13:51

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€581.50
23.01.24
€581.49
23.01.25
20.76%
13:51

buy
Teva Pharmaceutical Industries Ltd ADR

Start price
Target price
Perf. (%)
€10.75
23.01.24
€12.87
23.01.25
46.98%
13:44

buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€95.40
23.01.24
€110.32
23.01.25
30.62%
13:13

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€580.50
23.01.24
€625.12
23.01.25
20.97%
13:51

buy
Medpace Holdings Inc

Start price
Target price
Perf. (%)
€262.00
17.01.24
€286.92
17.01.25
36.26%
13:33